Merck & Co., Inc.MRKNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+4.8%
5Y CAGR+3.1%
Year-over-Year Change
Research and development spending
3Y CAGR
+4.8%/yr
vs +8.6%/yr prior
5Y CAGR
+3.1%/yr
Consistent
Acceleration
-3.8pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $15.60B | -13.1% |
| 2024 | $17.94B | -41.2% |
| 2023 | $30.53B | +125.4% |
| 2022 | $13.55B | +10.6% |
| 2021 | $12.24B | -8.6% |
| 2020 | $13.40B | +37.8% |
| 2019 | $9.72B | -0.3% |
| 2018 | $9.75B | -5.7% |
| 2017 | $10.34B | +0.8% |
| 2016 | $10.26B | - |